Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Influence of Different Components of the Tumor Microenvironment on Human Patient-Derived Lymphoma Cell Engraftment in Immmunodeficient Mice

Cordula Tschuch, PhD, Kerstin Klingner, Dorothee Lenhard, Cyrill Rentsch, MD PhD, Christian Wetterauer, Lukas Bubendorf, MD, Tatjana Vlajndic, MD, Milena Pantic, PhD, Lisa K Isbell, MD, Nikolas von Bubnoff, MD, Teppo Haapaniemi, PhD, Julia B. Schueler, DVM, PhD

Blood (2015) 126 (23): 1459.

https://doi.org/10.1182/blood.V126.23.1459.1459

Published: 2015

Journal Articles

Clinical and Pathologic Features of Intravascular Large B Cell Lymphoma: A Single Institution Experience

Kate Poropatich, MD, Kirtee Raparia, Jon Lomasney, Yi-Hua Chen, MD, Kristy L. Wolniak, MD PhD, Juehua Gao, MDPhD

Blood (2015) 126 (23): 5055.

https://doi.org/10.1182/blood.V126.23.5055.5055

Published: 2015

Journal Articles

A Rise in CNS Lymphoproliferative Disease Incidence Reveals a Protective Role of Calcineurin Inhibitors

Genevieve M. Crane, MD PhD, Helen Powell, PhD, Rumen Kostadinov, PhD, Richard F. Ambinder, MD PhD, Lode J. Swinnen, Michael Borowitz, MD PhD, Amy S. Duffield, MD PhD

Blood (2014) 124 (21): 3020.

https://doi.org/10.1182/blood.V124.21.3020.3020

Published: 2014

Journal Articles

Radiation Exposure As a Link to Primary Ocular Diffuse Large B Cell Lymphoma (PODLBCL) - a Possible Cluster Related to the Chernobyl Explosion

Sanford Kempin, MD, Paul Finger, MD, John Rescigno, MD, Jeffrey Rubin, MD, Walter Choi, MD, Rebecca Fisher, MD, Alexander Aizman, MD

Blood (2014) 124 (21): 5381.

https://doi.org/10.1182/blood.V124.21.5381.5381

Published: 2014

Journal Articles

Brain Lymphoma Treatment with Chemotherapy or Chemoradiotherapy from an Institution

Hassan Jalaeikhoo, MD, Bahman Shafaeean, MD, Manoutchehr Keyhani, MD

Blood (2012) 120 (21): 4859.

https://doi.org/10.1182/blood.V120.21.4859.4859

Published: 2012

Journal Articles

Ublituximab (TGTX-1101), a Novel, Third-Generation Anti-CD20 Antibody Demonstrates Enhanced Antitumor Activity Compared to Rituximab in Primary CNS and Intraocular Lymphoma Murine Models.

Sabrina Donnou, Rym Ben Abdelwahed-Bagga, Jérémie Cosette, Hanane Ouakrim, Lucile Crozet, Alexandra Jacquet, Wolf Herman Fridman, Catherine Sautès-Fridman, Peter Sportelli, Remi Urbain, Sylvain Fisson

Blood (2012) 120 (21): 2755.

https://doi.org/10.1182/blood.V120.21.2755.2755

Published: 2012

Journal Articles

Impact of Combined Anti-Retroviral Therapy on HIV-Associated Non-Hodgkin-Lymphoma - a Prospective European Multi-Cohort Study on Behalf of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group

Julia Bohlius, MD, MScPH

Blood (2008) 112 (11): 878.

https://doi.org/10.1182/blood.V112.11.878.878

Published: 2008

Journal Articles

Primary Central Nervous System Lymphoma (PCNSL): Intent-to-Treat Analysis of Monocenter Long-Term Experience.

Agnieszka Korfel, MD, Philipp Kiewe, MD, Lars Fischer, MD, Peter Mertus, PhD, Eckhard Thiel, PhD

Blood (2007) 110 (11): 1365.

https://doi.org/10.1182/blood.V110.11.1365.1365

Published: 2007

Journal Articles

Safety of Intrathecal Rituximab as Prophylaxis or Treatment in CD20+ Acute Lymphoblastic and Aggressive Lymphoma: Report from a Mexican Pilot Study.

Luis Villela, MD, Rocio Caballero-Caballero, MD, Josefa Piedras-Ross, Hetor Garcia-Herrera, MD, Dolores Mejia, MD, Jose R. Borbolla Escoboza, MD

Blood (2006) 108 (11): 4713.

https://doi.org/10.1182/blood.V108.11.4713.4713

Published: 2006

Journal Articles

Isolated Brain Parenchyma Relapse of Non-Hodgkin’s Lymphoma (NHL): A Descriptive Analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG).

Nancy D. Doolittle, PhD, Lauren Abrey, MD, Tamara Shenkier, Tali Siegal, Jacoline Bromberg, Edward Neuwelt, Carole Soussain, Patrick Johnston, Gerald Illerhaus, David Schiff, Tracy Batchelor, Silvia Montoto, Emanuele Zucca, Dale Kraemer

Blood (2006) 108 (11): 2026.

https://doi.org/10.1182/blood.V108.11.2026.2026

Published: 2006

Journal Articles

Comparison of Outcome of Unselected Patients with Diffuse Large B-Cell Lymphoma Diagnosed before and after Approval of Rituximab in France in This Indication.

Hervé Ghesquières, MD, Catherine Sebban, MD, Catherine Chassagne, MD, Liana Carausu, MD, Thérèse Gargi, CRA, Bertrand Favier, PhD, Irène Philip, MD, Jean Yves Blay, MD, PhD, Pierre Biron, MD

Blood (2005) 106 (11): 4766.

https://doi.org/10.1182/blood.V106.11.4766.4766

Published: 2005

Journal Articles

Combined treatment with temozolomide and poly(ADP-ribose) polymerase inhibitor enhances survival of mice bearing hematologic malignancy at the central nervous system site

Lucio Tentori, Carlo Leonetti, Marco Scarsella, Giulia d'Amati, Ilaria Portarena, Gabriella Zupi, Enzo Bonmassar, Grazia Graziani

Blood (2002) 99 (6): 2241–2244.

https://doi.org/10.1182/blood.V99.6.2241

Published: 2002

Journal Articles

Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy

Caroline Besson, Aicha Goubar, Jean Gabarre, Willy Rozenbaum, Gilles Pialoux, François-Patrick Châtelet, Christine Katlama, Frédéric Charlotte, Bertrand Dupont, Nicole Brousse, Michel Huerre, Jacqueline Mikol, Philippe Camparo, Karima Mokhtari, Micheline Tulliez, Dominique Salmon-Céron, François Boué, Dominique Costagliola, Martine Raphaël

Blood (2001) 98 (8): 2339–2344.

https://doi.org/10.1182/blood.V98.8.2339

Published: 2001

NARROW

Influence of Different Components of the Tumor Microenvironment on Human Patient-Derived Lymphoma Cell Engraftment in Immmunodeficient Mice

Clinical and Pathologic Features of Intravascular Large B Cell Lymphoma: A Single Institution Experience

A Rise in CNS Lymphoproliferative Disease Incidence Reveals a Protective Role of Calcineurin Inhibitors

Radiation Exposure As a Link to Primary Ocular Diffuse Large B Cell Lymphoma (PODLBCL) - a Possible Cluster Related to the Chernobyl Explosion

Brain Lymphoma Treatment with Chemotherapy or Chemoradiotherapy from an Institution

Ublituximab (TGTX-1101), a Novel, Third-Generation Anti-CD20 Antibody Demonstrates Enhanced Antitumor Activity Compared to Rituximab in Primary CNS and Intraocular Lymphoma Murine Models.

Impact of Combined Anti-Retroviral Therapy on HIV-Associated Non-Hodgkin-Lymphoma - a Prospective European Multi-Cohort Study on Behalf of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group

Primary Central Nervous System Lymphoma (PCNSL): Intent-to-Treat Analysis of Monocenter Long-Term Experience.

Safety of Intrathecal Rituximab as Prophylaxis or Treatment in CD20+ Acute Lymphoblastic and Aggressive Lymphoma: Report from a Mexican Pilot Study.

Isolated Brain Parenchyma Relapse of Non-Hodgkin’s Lymphoma (NHL): A Descriptive Analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG).

Comparison of Outcome of Unselected Patients with Diffuse Large B-Cell Lymphoma Diagnosed before and after Approval of Rituximab in France in This Indication.

Combined treatment with temozolomide and poly(ADP-ribose) polymerase inhibitor enhances survival of mice bearing hematologic malignancy at the central nervous system site

Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only